ReviewThe oncologist2018

EMA Review of Panobinostat (Farydak) for the Treatment of Adult Patients with Relapsed and/or Refractory Multiple Myeloma.

Kyriaki Tzogani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.